We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MicroRNAs Linked to Ability of Melanoma to Metastasize

By LabMedica International staff writers
Posted on 26 Jul 2011
Cancer researchers have identified a specific type of microRNA (miRNA) that in melanoma cells seems to be linked to the development of the ability to metastasize.

Investigators at New York University (New York, USA) explained in a paper published in the July 12, 2011, issue of the journal Cancer Cell that they initially performed miRNA analysis of human melanoma tissues, including primary and metastatic tumors. More...
Results revealed the presence of significantly high levels of a cluster of two miRNAs called miR-30b and miR-30d (miR-30b/30d) in both types of tumor cells. Higher levels of miR-30b/30d in metastatic tumor cells were linked to advanced stages of cancer, tumor progression, potential metastasis, and reduced overall patient survival.

At the molecular level, it was found that ectopic expression of miR-30b/30d promoted the metastatic behavior of melanoma cells by directly targeting the GalNAc transferase GALNT7, which resulted in increased synthesis of the immunosuppressive cytokine IL-10 and reduced immune cell activation and recruitment.

“Melanoma patients with higher levels of these miRNAs in their tumor cells are at greater risk for melanoma metastasis from their primary tumor,” said senior author Dr. Eva Hernando, assistant of pathology at New York University. “This study adds another piece to the melanoma puzzle showing how a few millimeter lesion on the skin’s surface can quickly metastasize by invading other parts of the body like the lungs and brain so aggressively. This study helps us better understand exactly why melanoma is so metastatic and suggests how miRNAs are a new potential therapeutic target for battling the disease.”

Related Links:
New York University



New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Analyzer
respons® UDS100
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.